Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease COPD, in the United States

Source :: Medical Devices & Surgical Technology Week. July 11, 2021, 85
Publication Year :: 2021
Abstract: 2021 JUL 11 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE [...]

Subjects :: Teva Pharmaceutical Industries Ltd. -- Product introduction
Bronchitis -- Care and treatment
Generic drugs -- Product introduction
Formoterol -- Product introduction
Pharmaceutical industry -- Product introduction
Health
Health care industry

Tools